PLTR Price Prediction: $196 or $170 — The AI Sovereignty Trade Is At a Crossroads
Peter Zhang Sep 26, 2026 13:32 UTC
Palantir sits at $190.05 with MACD momentum flatlined and institutional investors growing cautious, but the Q2 earnings story — 93% revenue growth, $3.4B in bookings — is still live. Bulls push for...
Stalling at the Ceiling: PLTR's Price Action Is Flashing a Warning
At $190.05 this morning, Palantir is down 1.23% on the session and pressing the underside of a congested resistance band that begins at $193.14 and hardens into a brick wall at $196.23. The 24-hour range of $189.14 to $194.23 tells the whole story: buyers are running right into that zone and getting turned back. The daily candle is effectively printing a bearish hangman against the top of its Bollinger Band expansion — and in a stock that just ripped 60%+ off June lows, that matters.
The catalyst underpinning this rally has been Palantir's Q2 FY2026 print, which was nothing short of explosive. Revenue surged 93% year-over-year to $1.94 billion, blowing past estimates of $1.81 billion. U.S. commercial revenue jumped 149% to $764 million, and the company booked a record $2.13 billion in U.S. commercial contract value in a single quarter. Then came AIPCon11 on September 10, where CEO Alex Karp doubled down on the "AI sovereignty" thesis — the idea that enterprises need to control their own AI infrastructure rather than remain dependent on model providers. UBS and DA Davidson both lifted their price targets to $250 following that event. That narrative is live, and Blockchain.news has been tracking the AI sovereignty theme as one of the defining equity stories of the back half of 2026. But narrative and price action are now diverging, and that's the friction traders need to trade around right now.
The immediate risk is real: a £330 million NHS contract in Britain faces a review clause expiring in February 2027, with lobbyists actively pushing Britain's new government to trigger the break provision. Palantir's domestic growth story dwarfs this exposure — $809 million in U.S. government revenue alone in Q2 — but headline risk from international contract disputes has a habit of rattling even fundamentally sound growth stocks.
A Chart That's Exhausted But Not Broken
Every moving average beneath this stock is trending higher — the 7-day SMA at $187.02, the 20-day and 50-day SMA both converging at $177.09, and the 200-day SMA anchored at $147.36. That structure screams a clean, intact uptrend with significant cushion. The problem is what's happening at the top of the range.
At 88% of the way up the Bollinger Band, PLTR is stretched. It hasn't been at the lower band since the summer lows. Momentum, measured through the MACD, has hit a zero-histogram read — the signal line and the MACD line are effectively sitting on top of each other. That's not a bearish reversal signal in isolation, but it confirms that the engine that drove this stock from $125 to $207.52 is now idling. RSI at 66 keeps bulls technically alive — it's not in overbought territory — but it's pushing the upper boundary of the neutral zone and hasn't got the same runway it did off the August lows.
The Stochastic %K at 84.89 with %D at 67.91 is the more pointed warning. When %K is crossing or approaching %D from above in the upper zone, short-term selling pressure typically follows. Add to this the positioning data: retail is heavily short at a 63.5% short ratio, while smart money — top traders — are sitting at 59.5% short. When both retail and institutional traders are leaning the same direction, the contrarian in you wants to fade them, but the chart structure here is offering them legitimate cover.
Support is well-defined. Immediate floor at $188.05, with strong support at $186.05 just below. A breach of $186 opens a deeper move toward $177, where the confluence of the 20-day and 50-day SMAs sits as the natural corrective target. An ATR of $5.35 means the stock can eat through those levels in two or three sessions of determined selling.
79x Forward Earnings in a World That Punishes Disappointment
Here is where PLTR's story gets genuinely uncomfortable. The stock trades at a trailing P/E of roughly 152x and a forward P/E of 79x. Against a market cap of approximately $460 billion at current prices, the company is trading at over 74x trailing sales. Analysts polled by S&P Global project full-year 2026 revenue of approximately $8.19 billion — growth of roughly 83% — and FY2027 revenue of $12.21 billion. EPS is forecast at $1.61 for FY2026 and $2.32 for FY2027. That's a genuinely staggering growth profile, and it's real: the numbers are verified, the contracts are public, and the Rule of 40 score of 155% puts Palantir in a league occupied by almost no other software company.
But even the bull camp must acknowledge what 79x forward earnings demands. It demands flawless execution. It demands that U.S. commercial revenue — which accelerated to 149% YoY growth last quarter — doesn't decelerate meaningfully in Q3 2026 results, due in early November. It demands that net dollar retention stays elevated and that those $5.6 billion infrastructure commitments translate into recognized revenue. Any of those metrics softening will trigger a violent multiple compression, not just a modest pullback.
The analyst consensus from Yahoo Finance as of today stands at an average target of approximately $196.84, a median of $205.10, a high of $255, and a bear case low of $80. That $80 target is Michael Burry's camp — he's re-established his bearish position with March 2027 puts in the low-to-mid $100 strike range and reportedly increased the size. With 20 buy ratings versus 2 sell ratings across the coverage universe, the Street is broadly in the bull camp. But the Street's bull camp has been chasing this stock upward with price target revisions that trail the share price rather than lead it. UBS started at $200 in June, moved to $220 in August, and landed at $250 in September — every step following the stock, not guiding it. That's an important distinction. Blockchain.news readers following the PLTR narrative should weigh those upgrades accordingly.
Northland Securities has a $190 price target with an Outperform rating, and Rosenblatt sits at $225, while Baird reiterates $200 with Outperform and Truist Securities holds a Buy with a $223 target. The 43.67% net profit margin and 28.34% return on equity are genuinely impressive for a company still growing at this pace, and the $8+ billion cash position provides meaningful insulation against any near-term execution stumble.
The Trade Setup: Two Clear Paths Over the Next 30 Days
The bull case is a breakout above $193.14 resistance on volume, followed by a confirmed close above $196.23. If that happens — likely triggered by a positive macro catalyst, a new AI government contract announcement, or favorable commentary into Q3 earnings season — PLTR has a clear path to $205 and potentially to test the $207.52 all-time high. With 20 buy-rated analysts and an AI sovereignty thesis that major government and enterprise customers are actively validating, the fundamental story can absolutely justify that move. Probability of the bull scenario playing out within 30 days: 40%.
The bear case is what keeps me cautious here. If the stock rejects $193 again today or early next week — which the current MACD flatline, stretched Bollinger position, and smart-money short positioning all suggest is likely — the initial pullback targets $188.05 and then $186.05. Lose $186 with any conviction and $177 is the next real floor, where both the 20-day and 50-day SMAs wait. That's a 7% drawdown from current levels, which is exactly one bad headline away given the NHS contract scrutiny and Burry's publicly amplified short. Probability of the bear scenario: 60% for the next 7–14 days.
Tactical setup: For traders looking to engage, the risk/reward favors waiting. Short-side: enter on a failed retest of $193–$194 resistance, stop above $196.50, target $177–$180. That's a roughly 3:1 reward-to-risk setup. Long-side: only worth initiating on a clean, high-volume break and daily close above $196.23, targeting $205–$207, with a stop at $190. Investors with a 30-day horizon should respect the fact that Q3 earnings in early November is the true inflection point for this trade — and that the stock does not need to do much more than print in-line numbers to see a "buy the rumor, sell the news" reaction given the pre-positioning evident in open interest. As covered on Blockchain.news, the convergence of AI enterprise demand and sovereign data mandates remains one of the most structurally durable investment themes of this cycle — but at 79x forward earnings, even the strongest themes need a breather.
Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 26, 2026 and reflect consensus estimates, not investment advice.
Image source: Shutterstock.jpg)